Emily Dookun

Emily Dookun is Scientific Director at FibroFind, responsible for translating the company’s scientific capability into clearly defined and well-executed client programs.

She works directly with biopharma partners to understand their scientific questions and ensures that studies are designed to deliver meaningful, decision-relevant outputs. Her role requires both scientific depth and strong commercial awareness, bridging the gap between complex biology and the practical needs of drug development teams.

Emily acts as a key interface between clients and plays a central role in shaping how FibroFind’s platform is applied across different programs, ensuring that each study is both scientifically rigorous and directly useful to the client.

Her contribution is critical to ensuring that FibroFind’s work is not only technically strong but also clearly interpretable and actionable.